Inovio Pharma (INO), GeneOne Initiate Patient Recruitment for MERS Vaccine Trial

January 28, 2016 8:34 AM EST Send to a Friend
Inovio Pharmaceuticals, Inc. (NASDAQ : INO) today announced the beginning of recruitment for its collaborative vaccine study for MERS (Middle ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login